0001181431-13-046225.txt : 20130823
0001181431-13-046225.hdr.sgml : 20130823
20130823090112
ACCESSION NUMBER: 0001181431-13-046225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130822
FILED AS OF DATE: 20130823
DATE AS OF CHANGE: 20130823
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 7
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8424
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
STREET 2: SUITE 7
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CHASE ANTHONY R
CENTRAL INDEX KEY: 0001223756
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 131056298
MAIL ADDRESS:
STREET 1: 10307 PACIFIC CENTER COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
rrd388999.xml
FORM 4
X0306
4
2013-08-22
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001223756
CHASE ANTHONY R
215 FIRST STREET, SUITE 7
CAMBRIDGE
MA
02412
1
0
0
0
Common Stock
2013-08-22
4
P
0
3500
32.6781
A
31744
D
This transaction was executed in multiple trades in prices ranging from $32.55 to $32.8099, inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares acquired at each respective price within the range set forth in this footnote.
/s/ Sandesh Mahatme For: Anthony R. Chase
2013-08-22